(Medical Xpress)—A possible link between colour vision and the development of myopia - or near-sightedness - has been discovered by an international group, including a researcher from The University of Western Australia.
Mar 1, 2013
0
0
With around 90% of drugs failing to make it to market, the potential for improving efficiency within the drug development industry is clear. Drugs designed to combat cancers suffer similar rates of failure for many reasons. ...
Aug 23, 2023
0
4
We all know the scene from countless courtroom dramas: A witness points at the defendant and confidently declares to judge and jury: "That's the one, that's who did it!" But is it? Perhaps. If that same witness was also confident ...
Nov 3, 2021
0
18
An Australian study reveals that people with the rare genetic disorder known as Prader-Willi Syndrome may have an impaired autonomic nervous system. This discovery opens up a new way of looking at the insatiable appetite ...
Nov 15, 2012
0
0
Multiple drug classes commonly prescribed for common medical conditions are capable of influencing the onset and progression of Alzheimer's disease, according to researchers at The Mount Sinai Medical Center. The findings ...
Jun 12, 2013
0
0
Researchers at Washington University School of Medicine in St. Louis have developed a way to attack synovial sarcoma—a rare tumor of soft tissues, such as ligaments and muscles—using an investigational drug that triggers ...
May 31, 2022
0
66
A preliminary study suggests that an investigational drug may help increase protein levels in babies with spinal muscular atrophy. The open-label study is released today and will be presented at the American Academy of Neurology's ...
Apr 18, 2018
0
4
Despite the importance of site investigators to the success of multicentre clinical trials, inadequate public information is available about their recruitment performance.
Dec 27, 2011
0
0
An international team of researchers led by clinicians at Weill Cornell Medical College have discovered a genetic Achilles' heel in an aggressive type of prostate cancer -- a vulnerability they say can be attacked by a targeted ...
Nov 17, 2011
1
0
Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries.
Sep 15, 2014
0
0
